Oral Medications segment dominated the Compounding Pharmacies Market - PowerPoint PPT Presentation

Loading...

PPT – Oral Medications segment dominated the Compounding Pharmacies Market PowerPoint presentation | free to download - id: 88a22a-ZmZkN



Loading


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation
Title:

Oral Medications segment dominated the Compounding Pharmacies Market

Description:

Get more details @ Compounding pharmacies market players include Fresenius Kabi, B. Braun Medical, Fagron, PharMEDium, Cantrell Drug Company, ITC Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy. Companies are consolidating their market position through adoption of strategies such as collaborations and acquisitions. – PowerPoint PPT presentation

Number of Views:13

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Oral Medications segment dominated the Compounding Pharmacies Market


1
Compounding Pharmacies Market forecast to hit
12bn by 2024 Global Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Key Insights from Compounding Pharmacies Market
  • Compounding Pharmacies Market will hold a
    valuation of more than USD 12 billion by 2024,
    with an estimated CAGR of 5 over 2017-2024.
  • In an era of consequential transformation in the
    healthcare delivery, compounding pharmacies
    market is charting a profitable growth curve.
  • Although a major chunk of pharmacists are
    involved in drug manufacturing, yet with the
    advancement of technology compounding has become
    an integral of pharmacy practice.
  • The expanding geriatric population base along
    with increasing customized medication
    requirements subject to alternative doses,
    flavor, formulations are stimulating the market
    dynamics.
  • The remarkable expansion of compounding
    pharmacies market is quite evident from its
    diversified product landscape which includes
    oral, rectal, inhaler, ophthalmic, topical, and
    parenteral.

3
Continued...
  • Growing individual preference toward consuming
    medicines in the form of tablets, capsules have
    significantly propelled the market demand from
    this domain.
  • Sedentary lifestyles along with heavy consumption
    of fat-rich foods have led to a rise of these
    cardiac diseases, which in a way is stimulating
    the necessity of compounded medications.
  • Pertaining to the increasing natality rates along
    with incapability of the commercial medicines to
    meet up with the customized pediatric formulation
    requirements, pediatric application will also
    register considerable revenue for compounding
    pharmacies market by 2024.
  • Compounding pharmacies market is characterized by
    some of the restraints such as lack of skilled
    lab personnel, excessive cost of the process, and
    issues related to its safety standards.
  • Some of the companies engaged in compounding
    pharmacies market include B. Braun Medical,
    PharMEDium, Fresenius Kabi, Village Compounding
    Pharmacy, and Cantrell Drug Company.

4
U.S. Compounding Pharmacies Market size, By
Product, 2013-2024 (USD Billion)
5
Table of Content
Chapter 1 Methodology 1.1
Methodology 1.1.1 Initial data
exploration 1.1.2 Statistical model and
forecast 1.1.3 Industry insights and
validation 1.1.4 Market definitions and
forecast parameters 1.2 Data Sources 1.2.1
Secondary 1.2.2 Primary Chapter 2
Executive Summary 2.1 Compounding
pharmacies industry 3600 synopsis, 2013 - 2024
2.1.1 Business trends 2.1.2
Product trends 2.1.3 Application trends
2.1.4 Therapeutic area trends
2.1.5 Regional trends
6
Table of Content
Chapter 3 Compounding Pharmacies Industry
Insights 3.1 Industry segmentation
3.2 Industry size and forecast, 2013
2024 3.3 Industry ecosystem analysis
3.3.1 Vendor matrix 3.3.2 Distribution
channel analysis 3.4 Industry impact
forces 3.4.1 Growth drivers 3.4.1.1
Increasing geriatric population and improved
longevity 3.4.1.2 Growing acceptance
of personalized medicines in U.S. and Europe
3.4.1.3 Increasing drug shortage,
worldwide 3.4.1.4 Convenience of using
compounded drugs 3.4.1.5 Growing drug
failure rate 3.4.2 Industry pitfalls
and challenges 3.4.2.1 Lack of
skilled lab technicians and pharmacists in
developed economies 3.4.2.2High cost of
equipment and maintenance of sterile environment
7
Table of Content
3.4.2.3 Changing regulatory specifications
3.4.2.4 Consumer perception towards
compounded drugs 3.5 Growth potential analysis
3.6 Regulatory landscape 3.6.1 U.S.
3.6.2 Europe 3.6.3 Australia
3.7 Reimbursement landscape 3.7.1 U.S.
3.7.2 Europe 3.7.3 Australia
3.8 Cost analysis of compounded medications
3.9 Innovative compounding technologies
3.9.1 Web-based quality management system
3.9.2 Digital tools 3.10 Porters
Analysis 3.11Competitive Landscape, 2016
3.11.1 Business overview 3.11.2
Strategic Dashboard 3.12 PESTEL
Analysis
8

Browse Full Market Research Report On
Compounding Pharmacies Market _at_
http//bit.ly/2rRiI1T Request for a Sample
of this Research Report _at_ https//www.gminsights.c
om/request-sample/detail/749 https//www.gminsigh
ts.com/request-sample/detail/49
9
Stay In Touch Website www.gminsights.com Soci
al Media
About PowerShow.com